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Objectives:	To	describe	mean	intracranial	pressure	after	aneurys-
mal	subarachnoid	hemorrhage,	to	identify	clinical	factors	associ-
ated	with	 increased	mean	 intracranial	 pressure,	 and	 to	 explore	
the	relationship	between	mean	intracranial	pressure	and	outcome.
Design:	Analysis	of	a	prospectively	collected	observational	data-
base.
Setting:	Neuroscience	ICU	of	an	academic	hospital.
Patients:	One	hundred	sixteen	patients	with	subarachnoid	hemor-
rhage	and	intracranial	pressure	monitoring.
Interventions:	None.
Measurements and Main Results:	Episodes	of	intracranial	pressure	
greater	than	20	mm	Hg	lasting	at	least	5	minutes	and	the	mean	intra-
cranial	pressure	for	every	12-hour	interval	were	analyzed.	The	highest	
mean	intracranial	pressure	was	analyzed	in	relation	to	demographic	
characteristics,	acute	neurologic	status,	initial	radiological	findings,	
aneurysm	treatment,	clinical	vasospasm,	and	ischemic	lesion.	Mortal-
ity	and	6-month	outcome	(evaluated	using	a	dichotomized	Glasgow	
Outcome	Scale)	were	also	introduced	in	multivariable	logistic	mod-
els.	Eighty-one	percent	of	patients	had	at	least	one	episode	of	high	
intracranial	pressure	and	36%	had	a	highest	mean	intracranial	pres-
sure	more	than	20	mm	Hg.	The	number	of	patients	with	high	intra-
cranial	pressure	peaked	3	days	after	subarachnoid	hemorrhage	and	
declined	after	day	7.	Highest	mean	intracranial	pressure	greater	than	
20	mm	Hg	was	significantly	associated	with	initial	neurologic	status,	
aneurysmal	rebleeding,	amount	of	blood	on	CT	scan,	and	ischemic	
lesion	within	72	hours	from	subarachnoid	hemorrhage.	Patients	with	
highest	mean	intracranial	pressure	greater	than	20	mm	Hg	had	sig-
nificantly	higher	mortality.	When	death,	vegetative	state,	and	severe	
disability	at	6	months	were	pooled,	however,	 intracranial	pressure	
was	not	an	independent	predictor	of	unfavorable	outcome.
Conclusions:	High	intracranial	pressure	is	a	common	complication	
in	the	first	week	after	subarachnoid	hemorrhage	in	severe	cases	
admitted	 to	 ICU.	Mean	 intracranial	 pressure	 is	 associated	with	
the	severity	of	early	brain	injury	and	with	mortality.	(Crit Care Med 
2015;	43:168–176)
Key Words:	 brain	 injury;	 Glasgow	 Outcome	 Scale;	 intracranial	
aneurysm;	 intracranial	 pressure;	 mortality;	 subarachnoid	
hemorrhage
Aneurysmal subarachnoid hemorrhage (SAH) has severe consequences, with mortality around 50% and good functional recovery in only one third of survivors (1). 
Among the multiple brain injury mechanisms after SAH, high 
intracranial pressure (HICP) may play an important role (2). 
Animal experiments have shown that the intracranial bleed-
ing causes an intracranial pressure (ICP) surge, lower cerebral 
perfusion pressure (CPP), and global ischemia (3). In patients, 
this mechanism may contribute to sudden death before hospi-
tal admission (12% of patients) (4). Elevated ICP has also been 
noted in the first week after SAH (5, 6).
Different mechanisms may raise ICP, such as global brain 
edema due to initial ischemia, intracerebral hematoma 
(ICH), cerebral infarction, acute and delayed hydrocephalus, 
or impaired cerebral autoregulation, occurring at different 
times during the hospital stay (7). Microdialysis studies have 
identified markers of brain metabolic crisis, leading to poor 
outcome, associated with HICP (8). Information about risk 
factors related to HICP after SAH and its time patterns is lim-
ited, especially in patients treated with endovascular coiling.
We put forward the following hypotheses: 1) HICP after 
SAH is common and not limited to the first hours after 
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bleeding; 2) specific clinical and radiological findings may 
be associated with the risk of HICP; 3) HICP affects the out-
come. We therefore studied 116 patients with SAH in order to 
track mean ICP changes after bleeding, to identify clinical fac-
tors associated with mean ICP greater than 20 mm Hg, and to 
explore the relationship between ICP and outcome.
MATERIALS AND METHODS
Patients and Clinical Management
We retrospectively examined a prospective observational data-
base; data were collected from July 2005 to February 2012 at 
the Neuroscience ICU, and the study was approved by the Eth-
ics Committee of the Fondazione IRCCS Ca’ Granda–Osped-
ale Maggiore Policlinico. Inclusion criteria were diagnosis of 
aneurysmal SAH, ICP monitored for more than 12 hours, and 
age older than 18 years.
Patients with SAH were managed according to international 
recommendations (9). After stabilization, the SAH diagnosis 
was confirmed in all patients by a CT scan followed by angi-
ography or CT angiography. Management included early clip-
ping or coiling of the aneurysm and surgical evacuation of the 
ICH where indicated. Acute symptomatic hydrocephalus was 
treated by drainage of the cerebrospinal fluid (CSF) through 
an external ventricular drain (EVD). EVD and CSF drain-
age are managed complying the following protocol based on 
radiological and clinical characteristics of patients:
 ● Patients with normal ICP (ICP ≤ 20 mm Hg and no ICP 
therapy) and without hydrocephalus: EVD closed.
 ● Patients with controlled ICP (ICP ≤ 20 mm Hg with 
standard medical therapy) and/or radiological signs of 
hydrocephalus: EVD opened during the first 10 minutes 
of every hour.
 ● Patients with high ICP (ICP > 20 mm Hg or maximal 
medical therapy) with or without radiological signs of 
hydrocephalus: EVD opened the first 50 minutes of every 
hour.
 ● In case of catheter obstruction and ICP-impaired wave-
form, a new EVD or an intraparenchymal probe is placed 
after CT scan and neurosurgeon consultation.
Patients were not given anticonvulsive prophylaxis. 
Hemoglobin levels were monitored at least twice daily and 
transfusion threshold was 9 g/dL. Oral nimodipine was given 
only if the first dose did not cause arterial hypotension. A sec-
ond CT scan was taken within the first 72 hours after treatment 
of the aneurysm to identify complications. In case of clinical 
vasospasm, angioplasty or intra-arterial papaverine infusion 
was employed in patients refractory to medical treatment 
(blood pressure rise after optimization of intravascular vol-
ume). Clinical vasospasm was defined as neuroworsening asso-
ciated with angiographic confirmation of vasospasm (arterial 
diameter narrowing > 20% from baseline). In our patients, 
neurologic status was monitored at least six times a day by the 
medical staff until discharge from the ICU. Neuroworsening 
was defined as loss of one point of the Glasgow Coma Scale 
(GCS, evaluating both side of the body for the motor com-
ponent) and/or the presence of new focal deficits. In case the 
neuroworsening was not attributed to systemic complications, 
patients were subjected to a new CT scan or MRI to rule out 
hydrocephalus/rebleeding and therefore to angiography (10).
ICP Monitoring and Treatment
ICP (a ventricular drain was placed in 93% of patients) was 
monitored in severe, comatose patients and/or cases with acute 
hydrocephalus. Patients were positioned with a slight head 
elevation (15–20°); ICP and arterial pressure transducers were 
zeroed with the external acoustic meatus as reference point for 
calculating CPP. ICP data were filtered and analyzed as previ-
ously described (11). Briefly, data were analyzed twice a day 
at 12-hour intervals (from 8 am to 8 pm and from 8 pm to 8 
am). ICP values obtained during CSF drainage, suction, and 
short-acting nursing were filtered and not considered during 
mean ICP calculations. After filtering, episodes of HICP (ICP 
> 20 mm Hg for at least 5 min) were noted. The mean ICP for 
the 12-hour interval was calculated and indicated as “mean 
ICP.” When monitoring was concluded, the highest mean ICP 
for each patient was classified as “highest mean ICP.” CPP was 
calculated as mean arterial pressure minus ICP. As for ICP, we 
noted the mean for the 12-hour interval, calling it “mean CPP.” 
When monitoring was concluded, the lowest mean CPP from 
each patient was classified as “lowest mean CPP.” In our cen-
ter, ICP probes are removed after 24 hours of ICP less than or 
equal to 20 mm Hg without any ICP treatment (including CSF 
drainage) after medical round at 8 am or 8 pm.
The aim of therapy was to keep ICP below 20 mm Hg and CPP 
above 65 mm Hg. ICP therapy intensity was classified as follows:
Standard medical therapy: sedation, mannitol, CSF 
withdrawal, mandatory mechanical ventilation to obtain 
Paco
2
 30–35 mm Hg, plasma Na higher than 140 mEq/L.
Maximal medical therapy: Paco
2
 less than 30 mm Hg, 
barbiturates, hypothermia.
Surgical therapy: ICH evacuation and/or decompression.
ICP therapy was defined as “low intensity” (standard medi-
cal therapy) or “high intensity” (maximal medical therapy and/
or surgery) for statistical analysis.
Clinical Variables
The database included age, sex, neurologic status, surgical/endo-
vascular treatment of the aneurysm, treatment complications 
(including intraoperative rebleeding, prolonged temporary clip-
ping, surgical/endovascular arterial occlusion, and thromboem-
bolic event), rebleeding, perioperative hypoxia defined as Spo
2
 
less than 90%, hypotension defined as systolic blood pressure 
less than 90 mm Hg, ICP therapy, clinical vasospasm and out-
come, episodes of anemia (hemoglobin < 9 g/dL), and infection. 
Neurologic status was assessed according to the World Federa-
tion of Neurological Surgeons grading scale (WFNS) and classi-
fied as severe (WFNS, 4–5) or mild (WFNS, 1–3) (12) before and 
after treatment of the aneurysm. Survival and 6-month Glasgow 
Outcome Scale (GOS) (13) were considered as clinical outcomes. 
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Scores were considered favorable (4–5) or unfavorable (1–3). 
Sixth month outcome was obtained through phone structured 
interviews by medical staff as suggested by Wilson et al (14).
Radiological Variables
Admission and follow-up CT scans were examined indepen-
dently by two of the authors. Presence of midline shift greater 
than 5 mm and ICH were recorded. The amount of blood in 
the scans was assessed using the Fisher scale (15). Hydrocepha-
lus was assessed by ventriculocranial ratio (16). Early lesions 
were defined as hypodense lesions visible on the CT taken 
within 72 hours from SAH; hypodense lesions occurring after 
this time were called “delayed lesions.” For statistical analysis, 
patients were initially classified as with or without early lesion. 
Additionally, they were dichotomized as with or without lesion 
at any time (Supplementary Fig. 1, Supplemental Digital Con-
tent 1, http://links.lww.com/CCM/B83).
The location of the aneurysm and the presence of angio-
graphic vasospasm were assessed by certified neuroradiologists.
Statistical Analysis
Continuous variables with normal distribution (age) are pre-
sented as mean and sd and variables with nonnormal distri-
bution as median and range (ICP). The Shapiro-Wilk test 
was used to assess normal distribution. Univariate analysis 
was used to explore variables related to highest mean ICP 
(> 20 mm Hg), mortality, and unfavorable outcome. The 
Mann-Whitney U test was used to analyze continuous vari-
ables and Fisher exact test for proportions. We explored the 
TAbLE 1.  Patients’ Clinical and Radiologic 
Characteristics
Variable n (%)
Female 86 (74)
Age (mean ± sd) 57 ± 13
Neurologic status before aneurysm treatment
  WFNS 1 17 (15)
  WFNS 2 24 (21)
  WFNS 3 8 (7)
  WFNS 4 33 (28)
  WFNS 5 34 (29)
Neurologic status after aneurysm treatment
  WFNS 1 7 (6)
  WFNS 2 13 (12)
  WFNS 3 2 (2)
  WFNS 4 58 (51)
  WFNS 5 33 (29)
Fisher grade
  1 0
  2 2 (2)
  3 85 (73)
  4 29 (25)
Intracerebral hematoma 53 (46)
Hydrocephalus 64 (55)
Rebleeding 46 (39)
Shift > 5 mm 24 (20)
Perioperative hypoxia 10 (8)
Perioperative hypotension 18 (15)
Hemoglobin < 9 g/dL 47 (40)
Infection 69 (59)
Aneurysm treatment
  Endovascular 84 (72)
  Surgical 29 (25)
  None 3 (3)
Treatment complication 61 (52)
Aneurysm location
  Anterior circulation 94 (81)
  Posterior circulation 22 (19)
Clinical vasospasm 34 (29)
CT hypodense lesion
  Early lesion 82 (71)
  Delayed lesion 55 (47)
  None 18 (15)
(Continued)
ICP
  Patients with episodes of high intracranial  
 pressurea
94 (81)
  Patients with highest mean ICP > 20 mm Hg 42 (36)
ICP treatment
  Low intensity 80 (69)
  High intensity 36 (31)
Therapeutic Paco2 < 35 mm Hg 63 (54)
Deaths in ICU 25 (21)
Glasgow Outcome Scale at sixth month
  1 35 (32)
  2 4 (4)
  3 42 (39)
  4 7 (6)
  5 20 (19)
  Missing 8
WFNS	=	World	Federation	of	Neurological	Surgeons	grading	scale,	ICP	=	
intracranial	pressure.
aICP	>	20	mm	Hg	for	at	least	5	min.
TAbLE 1. (Continued). Patients’ Clinical and 
Radiologic Characteristics
Variable n (%)
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relationship between ICP and outcomes using a restricted 
spline function and linearity Wald test. Since the Wald test was 
not significant, the relationship was considered linear.
Three binary logistic regression models were built, with 
mean ICP greater than 20 mm Hg, mortality, and unfavorable 
outcome as dependent variables. Initially, all the variables with 
p value less than 0.20 in univariate analysis were entered in the 
models as independent variables, then a backward stepwise 
selection method was used until all the remaining variables 
were significantly associated. Cases with missing values for any 
of the variables in the model were omitted. Finally, to assess 
the model adequacy, we used the Cessie-van Houwelingen 
statistics (an improvement on the Hosmer-Lemeshow test 
for goodness of fit) and R2 statistics. To assess discrimination, 
we calculated the area under receiver operating characteristic 
curve (c). Kaplan-Meier survival curves were compared using 
a log-rank test to assess the difference between patients with 
and without highest mean ICP greater than 20 mm Hg; p less 
than 0.05 was considered significant.
Analyses were done using R (version 2.15.1, 2012 The R 
Foundation for Statistical Computing, Vienna, Austria) and 
Prism 4 software (version 
4.01, Graph-Pad Software, San 
Diego, CA).
RESULTS
General Data
Out of 265 patients consecu-
tively admitted, 116 fulfilled 
the inclusion criteria; 144 were 
excluded because ICP was not 
monitored and five because 
complete imaging data were 
not available. Patients’ main 
details are reported in Table 1. 
Mean age was 57 years (± sd 
13) and 74% were female. Most 
were in poor neurologic con-
dition at admission, with 80% 
classified as WFNS 4–5 after 
aneurysm treatment. Rup-
tured aneurysms were coiled 
or clipped (72% and 25%, 
respectively) within 48 hours 
from admission in all but 
one patient. In three patients 
with GCS 3 and no brainstem 
reflexes, the aneurysm was 
not treated. Ninety-eight per-
cent presented massive SAH 
and were classified as Fisher 
3 (73%) or 4 (25%). Hydro-
cephalus was found in 55% 
of patients. ICH was detected 
in 46% with a midline shift 
greater than 5 mm in 20%. A 
CT early lesion was detected in 71% of patients and 47% devel-
oped a CT delayed lesion. Clinical vasospasm was observed in 
29% cases. Fifty-nine percent of patients developed an infec-
tion, but none of them had acute respiratory distress syn-
drome, septic shock, or multiple organ failure. Forty percent 
of subjects developed at least one episode of hemoglobin less 
than 9 g/dL.
Six months from the SAH (GOS, 4–5), 32% percent of 
patients were dead and only 25% had a favorable outcome. 
Eight patients were lost to follow-up.
Intracranial Hypertension Prevalence and  
Time Course
Median length of monitoring was 5.5 days (range, 0.5–15 
d), with a total of 17,088 hours monitored during the study. 
In 93% of patients, ICP was monitored using a ventricular 
catheter while in the others using subdural catheter. Eighty-
one percent of patients had at least one episode of HICP, 
and 36% had a highest mean ICP higher than 20 mm Hg; 
the median of the highest mean ICP was 18 mm Hg (range, 
6–96 mm Hg).
Figure 1. Intracranial hypertension time course. Upper panel shows the number of patients with intracranial 
pressure (ICP) monitoring day by day. Lower panel shows the number of patients with episodes of high 
intracranial pressure (HICP) (ICP > 20 mm Hg for at least 5 min) and with mean ICP higher than 20 mm Hg. 
SAH = subarachnoid hemorrhage.
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For 69%, standard medical therapy was used to control ICP, 
and in 13%, it was combined with evacuation of the ICH. In 
the remaining patients, maximal medical therapy (5%), surgi-
cal decompression (11%), or both (2%) were used.
The number of patients with mean ICP greater than 20 mm 
Hg or with episodes of HICP peaked on day 3 after SAH, 
slightly decreasing over the next days (Fig. 1). On day 7, the 
number of patients with mean ICP greater than 20 mm Hg was 
still similar to day 1.
Factors Associated With High ICP
Neurologic status, rebleeding, CT early lesions, and CT lesions 
at any time were significantly related with univariate analysis 
(Table 2). In the multivariable model, only the neurologic sta-
tus evaluated before aneurysm treatment, rebleeding, CT early 
TAbLE 2. Univariate Analysis for Factors 
Related to Highest Mean Intracranial 
Pressure Greater Than 20 mm Hg
Variable
Patients  
With  
Highest  
Mean ICP < 
20 mm Hg
Patients 
With  
Highest 
Mean ICP > 
20 mm Hg p
Age (mean ± sd) 59 ± 13 54 ± 13 0.06
Sex 0.18
  Female 58 28
  Male 16 14
Fisher 0.19
  3 51 34
  2 and 4 23 8
Shift > 5 mm 0.15
  Yes 12 12
  No 62 30
Intracerebral 
hematoma
0.33
  Yes 31 22
  No 43 20
Hydrocephalus 0.70
  Yes 42 22
  No 32 20
Aneurysm treatment 1
  Coiling 55 29
  Clipping 19 10
Complication 0.55
  Yes 38 23
  No 36 16
Neurologic status 
before treatment
< 0.001
  Mild 40 9
  Severe 34 33
Neurologic status 
after treatment
0.02
  Mild 19 3
  Severe 55 36
Rebleeding 0.01
  Yes 23 23
  No 51 19
CT early lesion < 0.001
  Yes 45 37
  No 29 5
(Continued)
Clinical vasospasm 0.39
  Yes 24 10
  No 50 32
Aneurysm location 0.22
  Anterior 57 37
  Posterior 17 5
CT lesion at any time 0.01
  Yes 58 40
  No 16 2
Perioperative 
hypoxia
0.49
  Yes 5 5
  No 69 37
Perioperative 
hypotension
0.79
  Yes 11 7
  No 63 35
Hemoglobin  
< 9 g/dL
0.02
  Yes 24 23
  No 50 19
Infection 0.44
  Yes 46 23
  No 28 19
ICP	=	intracranial	pressure.
TAbLE 2. (Continued). Univariate Analysis for 
Factors Related to Highest Mean Intracranial 
Pressure Greater Than 20 mm Hg
Variable
Patients  
With  
Highest  
Mean ICP < 
20 mm Hg
Patients 
With  
Highest 
Mean ICP > 
20 mm Hg p
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lesions, and Fisher grade were significantly related with high-
est mean ICP greater than 20 mm Hg (Table 3). Indicators of 
model performance showed R2 = 0.31, goodness of fitness with 
p = 0.09 and c = 0.77.
Relationship between ICP and Outcomes
Patients with highest mean ICP greater than 20 mm Hg had 
higher mortality (Fig. 2). Most deaths occurred in the first 7 
days after SAH. There was a linear relationship between high-
est mean ICP and mortality (Supplementary Fig. 2, Supple-
mental Digital Content 1, http://links.lww.com/CCM/B83). In 
addition, sex, neurologic status after treatment, CT lesion at 
any time, highest mean ICP, and ICP therapy intensity were 
associated with mortality at 6 months in the univariate analy-
sis (Table 4). When those variables were entered in a multi-
variable model, only highest mean ICP appeared associated 
with mortality (Table 5). Model performance showed a good-
ness of fit p = 0.80, c = 78, and R2 = 0.4.
A multivariable model was used to evaluate which variables 
were associated with unfavorable outcome at 6 months; in the 
univariate analysis, factors such as age, neurologic status, early 
CT lesion, CT lesion at any time, highest mean ICP, and ICP 
therapy were significantly associated with unfavorable out-
come (Table 4); only neurologic status, age, and CT lesions 
at any time remained significantly associated in multivariable 
analysis (Table 5). Model performance showed R2 = 0.47, good-
ness of fit with p = 0.96 and c = 0.87.
CPP After SAH
The median of the lowest mean CPP was 68 mm Hg (range, 
5–104 mm Hg); in 56%, the lowest mean CPP was more than 
65 mm Hg. In 31 out 42 patients (74%), highest mean ICP 
greater than 20 mm Hg was associated with mean CPP lower 
than 65 mm Hg.
Neurologic status, CT early lesions, CT lesions at any 
time, aneurysm location, and perioperative hypotension 
were significantly related with lowest mean CPP less than 
65 mm Hg in univariate analysis (Supplementary Table 1, 
Supplemental Digital Content 1, http://links.lww.com/CCM/
B83). In the multivariable model, only the neurologic status 
evaluated before aneurysm treatment and CT early lesion 
were significantly related with low CPP, whereas periopera-
tive hypotension showed a relationship marginally significant 
(Supplementary Table 2, Supplemental Digital Content 1, 
http://links.lww.com/CCM/B83). Indicators of model perfor-
mance showed R
2
 = 0.33, goodness of fitness with p = 0.14 and 
c = 0.77. Lowest mean CPP showed significant relationship 
with mortality and unfavorable outcome in univariate analy-
sis (Table 4) but not in the multivariable models.
DISCUSSION
In this study, HICP was common after SAH, but more frequent 
in patients with severe brain injury, and was associated with 
higher mortality. HICP episodes occurred in 80% of our cases, 
and more than one third had sustained HICP, lasting more than 
12 hours, despite conventional and aggressive treatment. This 
confirms results from other groups (5, 6). ICP was still high in 
a considerable number of patients until day 7 after bleeding.
In the multivariable analysis, the independent predictors of 
prolonged HICP were the amount of blood on CT scan, rebleed-
ing, early ischemic lesion, and poor neurologic status. HICP 
therefore seems related to the severity of early brain injury. Our 
data did not show any relationship between HICP and hydro-
cephalus probably due to the high prevalence of EVD place-
ment and CSF drainage based on radiological signs or clinical 
suspicion of this common complication. However, while ICP in 
mild patients was well controlled with CSF withdrawal, severe 
patients required a more aggressive treatment (Supplementary 
Result 1, Supplemental Digital Content 1, http://links.lww.com/
CCM/B83). This finding suggests that in the severe group, CSF 
drainage is not enough to control HICP, which is likely to be 
related to other causes (as global ischemia secondary to aneu-
rysm bleeding, early ischemic lesions, etc.) rather than solely to 
CSF circulation disturbances. We were not able to show any sig-
nificant relationship between ICP and clinical vasospasm even 
though a substantial number of patients had HICP up to day 7; 
probably cerebral ischemia due to vasospasm was not enough 
to cause HICP, independent of other predictors.
HICP was associated with more deaths, mainly in the ICU; 
in those patients, HICP was probably a final common pathway 
to death. Our data, however, showed no relationship between 
TAbLE 3. Multivariable Model for Highest 
Mean Intracranial Pressure Greater Than 
20 mm Hg
Variable OR (95% CI) p
Neurologic status before 
aneurysm treatment 
(severe vs mild)
3.71 (1.42–9.66) 0.007
Rebleeding (yes vs no) 3.47 (1.38–8.69) 0.008
Fisher grade (2–4 vs 3) 0.29 (0.09–0.87) 0.027
CT early lesion (yes vs no) 4.32 (1.37–13.57) 0.012
OR	=	odds	ratio.
Figure 2. Kaplan-Meier survival curves for patients with highest mean 
intracranial pressure (ICP) less than or equal to 20 mm Hg, between 20 
and 30 mm Hg, and higher than 30 mm Hg. Log-rank test p < 0.01.  
SAH = subarachnoid hemorrhage.
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TAbLE 4. Univariate Analysis for Factors Related to 6-Month Mortality and  
Unfavorable Outcome
Variable Survivors Deaths p
Favorable 
Outcome
Unfa-
vorable 
Outcome p
Age (mean ± sd) 56 ± 12 60 ± 14 0.44 52 ± 12 59 ± 13 0.013
Sex 0.039 1
  Female 58 21 20 59
  Male 15 14 7 22
Fisher 0.49 1
  3 51 27 20 60
  2 and 4 22 8 7 21
Shift > 5 mm 0.61 0.17
  Yes 17 6 3 20
  No 56 29 24 61
Intracerebral hematoma 0.86 0.07
  Yes 34 15 8 41
  No 39 20 19 40
Hydrocephalus 0.53 0.82
  Yes 38 21 14 45
  No 35 14 13 36
Aneurysm treatment 0.33 0.79
  Coiling 52 26 21 57
  Clipping 21 6 6 21
Complication 1 0.65
  Yes 38 17 13 42
  No 35 15 14 36
Neurologic status before treatment 0.29 0.02
  Severe 41 24 11 54
  Mild 32 11 16 27
Neurologic status after treatment 0.052 < 0.001
  Severe 56 30 15 71
  Mild 17 2 12 7
Rebleeding 0.53 0.49
  Yes 28 16 9 35
  No 45 19 18 46
CT early lesion 0.07 0.001
  Yes 48 29 12 65
  No 25 6 15 16
(Continued)
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ICP and unfavorable outcome (pooling death, vegetative state, 
and severe disability). A possible interpretation is that impor-
tant pathological events affecting brain integrity and function 
after SAH do not necessarily cause HICP. Regional hypoper-
fusion and ischemia, detected in microdialysis and perfusion 
studies (17, 18), may not be disclosed by a global monitor of 
increased intracranial volume like ICP.
Our findings confirm and extend results from two simi-
lar studies (5, 6). Heuer et al (5) reported daily highest mean 
ICP greater than 20 mm Hg in 54% of 433 surgically treated 
patients and a relationship between HICP, early severity, and 
mortality; Ryttlefors et al (6) reported episodes of HICP in 
25% of 99 patients; HICP was associated with clinical deterio-
ration but not with unfavorable outcome. Furthermore, our 
results seem to be in line with data from patients with trau-
matic brain injury (19, 20) and intracerebral hemorrhage (21, 
22) that showed a strong relationship of high ICP with mortal-
ity but weaker with unfavorable functional outcome.
Our work has certain limitations. This was a single-center 
observational study in selected patients, so any generalization 
Clinical vasospasm 1 0.81
  Yes 22 11 9 24
  No 51 24 18 57
CT lesion at any time 0.018 < 0.001
  Yes 58 34 16 76
  No 15 1 11 5
Perioperative hypoxia 0.46 1
  Yes 5 4 2 7
  No 68 31 25 74
Perioperative hypotension 0.16 1
  Yes 15 3 4 14
  No 58 32 23 67
Highest mean intracranial pressure (median 
and range)
16 (6–57) 32 (6–96) < 0.001 15 (6–26) 19 (6–96) 0.003
Lowest mean cerebral perfusion pressure 
(median and range)
69 (37–104) 55 (5–98) < 0.001 72 (47–104) 64 (5–98) 0.018
Aneurism location 0.26
  Anterior 57 29 0.29 20 68
  Posterior 16 4 7 13
ICP treatment 0.045 0.03
  High intensity 18 16 4 30
  Low intensity 55 19 23 51
Hemoglobin < 9 g/dL 0.83 0.07
  Yes 29 15 7 37
  No 44 20 20 44
Paco2 < 35 mm Hg 0.06 0.38
  Yes 36 24 13 47
  No 37 11 14 34
Infection 0.83 0.069
  Yes 43 22 12 53
  No 30 13 15 28
TAbLE 4. (Continued). Univariate Analysis for Factors Related to 6-Month Mortality and 
Unfavorable Outcome
Variable Survivors Deaths p
Favorable 
Outcome
Unfavorable 
Outcome p
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calls for caution. The majority of patients underwent ICP mon-
itoring after clipping/coiling of the aneurysm, surgical removal 
of any large intracranial mass, EVD placement with CSF drain-
age, and so on. It is likely, therefore, that the real prevalence and 
severity of HICP, especially in the first hours after bleeding, 
was underestimated in our recordings. For the same reason, the 
real impact of hydrocephalus on HICP was probably mitigated. 
HICP was treated aggressively, so this investigation obviously 
does not represent the natural course of ICP after SAH.
In our center, studies about ICP waveform and cerebral 
autoregulation are not performed systematically, and we 
were unable to include these data in our analysis. Whether 
these variables had a relationship with HICP and outcome in 
patients with SAH could be the subject of future studies focus-
ing on a limited number of patients (23).
Additionally, we focused our investigations on intracranial 
features and did not fully analyze systemic complications, such 
as fever, electrolyte imbalance, and cardiac and respiratory fail-
ure, which may affect ICP and outcome. The number of patients 
that developed cardiac failure or acute respiratory distress syn-
drome was too small to include these complications in the mod-
els. We tried to indirectly account them considering patients 
with hypotension and hypoxia, but no relationship was found.
Lacking a randomized control group, the study could not dem-
onstrate the benefits of monitoring and treating ICP in patients 
with severe SAH. However, our findings indicate that HICP is fre-
quent and plays an important role in the clinical course of SAH.
CONCLUSIONS
High ICP is a common complication in the first week after SAH 
in severe cases admitted to ICU. It is associated with severity of 
early brain injury and with mortality.
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TAbLE 5. Multivariable Model for 6-Month 
Unfavorable Outcome and Mortality
Variable OR (95% CI) p
Unfavorable outcome
  Neurologic status after  
 aneurysm treatment  
 (severe vs mild)
5.82 (1.56–21.73) 0.008
  CT lesion at any time 9.12 (2.09 39.7) 0.003
  Age (per unit) 1.07 (1.02–1.12) 0.002
  Highest mean ICP  
 (per mm Hg)
1.05 (0.99–1.12) 0.146
Mortality
  Highest mean ICP  
 (per mm Hg)
1.08 (1.04–1.23) 0.001
OR	=	odds	ratio,	ICP	=	intracranial	pressure.
